Buprenorphine/Naloxone (Suboxone)

Part 2 of 4 | Use in the Opioid Toxicity and Withdrawal Medical Directive

A sneak peek into the 2024 MCME

Rationale For This Tip

SWORBHP will be providing education about the use of Suboxone during MCME 2024. Here we present part 2 of 4 on the drug to get you excited for 2024!

Buprenorphine/Naloxone (Suboxone) is now listed within the Opioid Toxicity and Withdrawal Medical Directive for paramedics to treat patients suffering from withdrawal symptoms associated with opioid use.

See post #1 for the rationale and description of Suboxone.

No additional resources available for this #SWORBHPTip.